Kang KA, Lee KH, Chae S, et al. Eckol isolated from Ecklonia cava attenuates oxidative stress induced cell damage in lung fibroblast cells. FEBS Lett 2005;579:6295-304. View abstract.

Athukorala Y, Kim KN, Jeon YJ. Antiproliferative and antioxidant properties of an enzymatic hydrolysate from brown alga, Ecklonia cava. Food Chem Toxicol 2006;44:1065-74. View abstract.

Shin HC, Hwang HJ, Kang KJ, Lee BH. An antioxidative and antiinflammatory agent for potential treatment of osteoarthritis from Ecklonia cava. Arch Pharm Res 2006;29:165-71. View abstract.

Kang KA, Zhang R, Lee KH, et al. Protective effect of triphlorethol-A from Ecklonia cava against ionizing radiation in vitro. J Radiat Res (Tokyo) 2006;47:61-8. View abstract.

Kim MM, Ta QV, Mendis E, et al. Phlorotannins in Ecklonia cava extract inhibit matrix metalloproteinase activity. Life Sci 2006;79:1436-43. View abstract.

Kang K, Hwang HJ, Hong DH, et al. Antioxidant and antiinflammatory activities of ventol, a phlorotannin-rich natural agent derived from Ecklonia cava, and its effect on proteoglycan degradation in cartilage explant culture. Res Commun Mol Pathol Pharmacol 2004;115-116:77-95. View abstract.

Kim SK, Lee DY, Jung WK, et al. Effects of Ecklonia cava ethanolic extracts on airway hyperresponsiveness and inflammation in a murine asthma model: role of suppressor of cytokine signaling. Biomed Pharmacother 2008;62:289-96. View abstract.

Park E, Ahn GN, Lee NH, et al. Radioprotective properties of eckol against ionizing radiation in mice. FEBS Lett 2008;582:925-30. View abstract.

Artan M, Li Y, Karadeniz F, et al. Anti-HIV-1 activity of phloroglucinol derivative, 6,6'-bieckol, from Ecklonia cava. Bioorg Med Chem 2008;16:7921-6. View abstract.

Jung WK, Ahn YW, Lee SH, et al. Ecklonia cava ethanolic extracts inhibit lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in BV2 microglia via the MAP kinase and NF-kappaB pathways. Food Chem Toxicol 2009;47:410-7. View abstract.

Li Y, Qian ZJ, Ryu B, et al. Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava. Bioorg Med Chem 2009;17:1963-73. View abstract.

Lee SH, Jeon YJ. Efficacy and safety of a dieckol-rich extract (AG-dieckol) of brown algae, Ecklonia cava, in pre-diabetic individuals: a double-blind, randomized, placebo-controlled clinical trial. Food Funct. 2015;6(3):853-8. View abstract.

Oh JK, Shin YO, Yoon JH, Kim SH, Shin HC, Hwang HJ. Effect of supplementation with Ecklonia cava polyphenol on endurance performance of college students. Int J Sport Nutr Exerc Metab. 2010;20(1):72-9. View abstract.

Kim J, Jung Y, Lee E, et al. Urinary metabolomic profiling analysis and evaluation of the effect of Ecklonia cava extract intake. Nutrients 2020;12(5):1407. View abstract.

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), Turck D, et al. Safety of Ecklonia cava phlorotannins as a novel food pursuant to Regulation (EC) No 258/97. EFSA J 2017;15(10):e05003. View abstract.

Lee HJ, Kwon O, Kim JY. Supplementation of a polyphenol extract from Ecklonia cava reduces body fat, oxidative and inflammatory stress in overweight healthy subjects with abdominal obesity: A randomized, placebo-controlled, double-blind trial. J. Functional Foods. 2018;46:356-64.

Lee DH, Park MY, Shim BJ, et al. Effects of Ecklonia cava polyphenol in individuals with hypercholesterolemia: a pilot study. J Med Food. 2012;15(11):1038-44. View abstract.

Choi EK, Park SH, Ha KC, et al. Clinical trial of the hypolipidemic effects of a brown alga Ecklonia cava extract in patients with hypercholesterolemia. Int. J. Pharm. 2015;11:798-805.